1. Home
  2. About NIDDK
  3. Staff Directory
  4. Thomas Eggerman, M.D., Ph.D.

Thomas Eggerman, M.D., Ph.D.

Photo of Thomas Eggerman
Cystic fibrosis research and translation centers, Cystic Fibrosis basic research and clinical trials, rare metabolic diseases basic and clinical trials, clinical islet transplantation registry; advanced artificial pancreas clinical trials, post COVID-19 new onset diabetes, Integrated Islet Distribution Program, Human Islet Research Network (HIRN)

Responsibilities & Activities

I am the program officer for Cystic Fibrosis grants and Centers programs. The focus is on the non-pulmonary aspects of Cystic Fibrosis.

I am also the program officer for the Rare Metabolic Disease and Advanced Artificial Pancreas Clinical Trials programs.

Additionally, I am the program director for the Human Islet Research Network (HIRN) Enhancement Center and the Integrated Islet Distribution Program (IIDP).  I am the Scientific Officer for the Collaborative Islet Transplantation Registry, the Covid Diabetes Assessment Consortium and the Lysosomal Disease Network.

Research Programs

Cystic Fibrosis
Etiology, molecular pathogenesis, pathophysiology, diagnosis, and treatment of cystic fibrosis and its complications.

Cystic Fibrosis Research & Translation Centers
CFRTCs provide support for basic, preclinical, and clinical research efforts to advance scientific knowledge and new therapies for CF.

Endocrine Pancreas
Biology, development, and function of the endocrine pancreas and clinical studies on islet transplantation for type 1 diabetes treatment.

Genetic Metabolic Disease
Basic and clinical studies on the pathophysiology and treatment of inborn errors of metabolism and rare genetic metabolic diseases.

Committees & Working Groups

  • Type 1 Diabetes Working Group, Member
  • HIRN Working Group, Member
  • DEM Clinical Oversight Committee, Member
  • Rare Disease Clinical Trials Network, Member